Borealis Biosciences
PrivateLast Round
Series A
Extension
Dec 19, 2024
Total Funding Raised
$210M
Company Overview
Borealis Biosciences is a biotechnology company that develops next-generation xRNA-based medicines for kidney diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Borealis Biosciences Comparables
Compare Borealis Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Judo Bio | 84% | |
| Purespring Therapeutics | 83% | |
| Zeal Therapeutics, Inc. | 82% | |
Borealis Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 19, 2024 | ||||
| Series A | Aug 22, 2024 |
Key People
Founding team and executive leadership
Borealis Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village BioPartners | Series A, Series A Extension |
| Versant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2023
Predecessor Chinook Therapeutics acquired by Novartis for $3.5B.
Borealis Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Borealis Biosciences's valuation, stock price, and market status.